MCH Best. NPM 1: Well-Woman Visit
Strategy. Expanded Insurance Coverage/Medicaid Eligibility
Approach. Adopt a protocol to ensure that all persons in maternal, child, and adolescent health programs are referred for enrollment in health insurance.
Overview. Evidence suggests that the effect of expansion to near-universal health insurance coverage for preventive screenings may lead to a large uptake in preventive screening for patients.”1
Evidence. Moderate. There is evidence to suggest that expanded insurance coverage is effective. Access the peer-reviewed evidence on expanded insurance coverage and cost-sharing requirements through the MCH Digital Library. (Read more about understanding evidence ratings).
Target Audience. Payer.
Outcome. Percent of women with a past year preventive visit. For detailed outcomes related to each study supporting this strategy, click on the peer-reviewed evidence link above and read the "Intervention Results" for each study.
Examples from the Field. There are currently 6 ESMs across all states/jurisdictions that use this strategy directly or intervention components that align with this strategy. Access descriptions of these ESMs through the MCH Digital Library. You can use these ESMs to see how other Title V agencies are addressing the NPM.
Sample ESMs. Using the approach “Adopt a protocol to ensure that all persons in maternal, child, and adolescent health programs are referred for enrollment in health insurance,” here are sample ESMs you can use as a model for your own measures using the Results-Based Accountability framework (for suggestions on how to develop programs to support this strategy, see The Role of Title V in Adapting Strategies):
Note. ESMs become stronger as they move from measuring quantity to measuring quality (moving from Quadrants 1 and 3, respectively, to Quadrants 2 and 4) and from measuring effort to measuring effect (moving from Quadrants 1 and 2, respectively, to Quadrants 3 and 4).
1 Sabik, L. M., & Bradley, C. J. (2016). The impact of near‐universal insurance coverage on breast and cervical cancer screening: evidence from Massachusetts. Health economics, 25(4), 391-407.